JP2018199643A5 - - Google Patents

Download PDF

Info

Publication number
JP2018199643A5
JP2018199643A5 JP2017105133A JP2017105133A JP2018199643A5 JP 2018199643 A5 JP2018199643 A5 JP 2018199643A5 JP 2017105133 A JP2017105133 A JP 2017105133A JP 2017105133 A JP2017105133 A JP 2017105133A JP 2018199643 A5 JP2018199643 A5 JP 2018199643A5
Authority
JP
Japan
Prior art keywords
food
improving agent
drug according
brain
brain function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017105133A
Other languages
English (en)
Japanese (ja)
Other versions
JP6998133B2 (ja
JP2018199643A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from JP2017105133A external-priority patent/JP6998133B2/ja
Priority to JP2017105133A priority Critical patent/JP6998133B2/ja
Priority to EP17911728.8A priority patent/EP3643314B1/en
Priority to KR1020197038343A priority patent/KR20200011490A/ko
Priority to IL270936A priority patent/IL270936B2/en
Priority to CN201780091325.7A priority patent/CN110691599B/zh
Priority to PCT/JP2017/043429 priority patent/WO2018220886A1/ja
Priority to KR1020227004771A priority patent/KR20220025912A/ko
Priority to US16/617,540 priority patent/US11278564B2/en
Priority to BR112019024953-2A priority patent/BR112019024953A2/pt
Publication of JP2018199643A publication Critical patent/JP2018199643A/ja
Publication of JP2018199643A5 publication Critical patent/JP2018199643A5/ja
Priority to JP2021117563A priority patent/JP2021169506A/ja
Publication of JP6998133B2 publication Critical patent/JP6998133B2/ja
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017105133A 2017-05-28 2017-05-28 リポ多糖を用いた脳機能改善剤、食品及び医薬品 Active JP6998133B2 (ja)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP2017105133A JP6998133B2 (ja) 2017-05-28 2017-05-28 リポ多糖を用いた脳機能改善剤、食品及び医薬品
KR1020227004771A KR20220025912A (ko) 2017-05-28 2017-12-04 리포 다당을 사용한 뇌기능 개선제, 식품 및 의약품
BR112019024953-2A BR112019024953A2 (pt) 2017-05-28 2017-12-04 Agente, alimento ou medicamento para melhorar a função cerebral
IL270936A IL270936B2 (en) 2017-05-28 2017-12-04 Brain function-improving agent, food, and medicine using lipopolysaccharide
CN201780091325.7A CN110691599B (zh) 2017-05-28 2017-12-04 使用脂多糖的脑功能改善剂、食品和药品
PCT/JP2017/043429 WO2018220886A1 (ja) 2017-05-28 2017-12-04 リポ多糖を用いた脳機能改善剤、食品及び医薬品
EP17911728.8A EP3643314B1 (en) 2017-05-28 2017-12-04 Brain function-improving agent, food, and medicine using lipopolysaccharide
US16/617,540 US11278564B2 (en) 2017-05-28 2017-12-04 Brain function-improving agent, food, and medicine using lipopolysaccharide
KR1020197038343A KR20200011490A (ko) 2017-05-28 2017-12-04 리포 다당을 사용한 뇌기능 개선제, 식품 및 의약품
JP2021117563A JP2021169506A (ja) 2017-05-28 2021-07-16 リポ多糖を用いた脳機能改善剤、食品及び医薬品

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017105133A JP6998133B2 (ja) 2017-05-28 2017-05-28 リポ多糖を用いた脳機能改善剤、食品及び医薬品

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021117563A Division JP2021169506A (ja) 2017-05-28 2021-07-16 リポ多糖を用いた脳機能改善剤、食品及び医薬品

Publications (3)

Publication Number Publication Date
JP2018199643A JP2018199643A (ja) 2018-12-20
JP2018199643A5 true JP2018199643A5 (enExample) 2020-05-14
JP6998133B2 JP6998133B2 (ja) 2022-01-18

Family

ID=64455394

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017105133A Active JP6998133B2 (ja) 2017-05-28 2017-05-28 リポ多糖を用いた脳機能改善剤、食品及び医薬品
JP2021117563A Pending JP2021169506A (ja) 2017-05-28 2021-07-16 リポ多糖を用いた脳機能改善剤、食品及び医薬品

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021117563A Pending JP2021169506A (ja) 2017-05-28 2021-07-16 リポ多糖を用いた脳機能改善剤、食品及び医薬品

Country Status (8)

Country Link
US (1) US11278564B2 (enExample)
EP (1) EP3643314B1 (enExample)
JP (2) JP6998133B2 (enExample)
KR (2) KR20220025912A (enExample)
CN (1) CN110691599B (enExample)
BR (1) BR112019024953A2 (enExample)
IL (1) IL270936B2 (enExample)
WO (1) WO2018220886A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6998133B2 (ja) * 2017-05-28 2022-01-18 自然免疫制御技術研究組合 リポ多糖を用いた脳機能改善剤、食品及び医薬品
US20220152090A1 (en) * 2020-11-13 2022-05-19 National Health Research Institutes Method for treating amyloidogenic disease
JP7679216B2 (ja) * 2021-04-07 2025-05-19 有限会社バイオメディカルリサーチグループ リポ多糖製造方法、リポ多糖、及びその配合物
KR20250025712A (ko) 2022-06-22 2025-02-24 겐이치로 소마 당뇨병성 인지증에 대한 예방약 및 치료약
KR102555274B1 (ko) 2022-12-03 2023-07-13 김환배 분리형 측면 미세먼지 집진휀스로 세척이 용이한 고기구이기

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2444480B1 (en) 2003-09-26 2016-09-07 Gen-Ichiro Soma Method for fermentation and cultivation, fermented plant extract, fermented plant extract powder, and composition containing the extract of fermented plant
TW201618790A (zh) * 2014-10-02 2016-06-01 Nitto Denko Corp 經皮投與用疫苗醫藥組合物
JP2016193865A (ja) 2015-03-31 2016-11-17 キリン株式会社 ミクログリア貪食活性亢進のための組成物及びミクログリア貪食活性亢進作用の予測方法
JP6780240B2 (ja) 2015-12-11 2020-11-04 株式会社リコー 制御装置、液体を吐出する装置、印刷物の生産方法及びプログラム
JP6998133B2 (ja) * 2017-05-28 2022-01-18 自然免疫制御技術研究組合 リポ多糖を用いた脳機能改善剤、食品及び医薬品

Similar Documents

Publication Publication Date Title
JP2018199643A5 (enExample)
WO2017022962A8 (ko) Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
JP2016034978A5 (enExample)
JP2014198723A5 (enExample)
JP2015515985A5 (enExample)
JP2015131825A5 (enExample)
JP2015500223A5 (enExample)
WO2016142708A3 (en) Pharmaceutical composition
JP2019535760A5 (ja) ガボキサドールを用いた注意欠陥多動性障害(adhd)の治療方法
JP2020536085A5 (enExample)
JP2017505809A5 (enExample)
JP2016515550A5 (enExample)
PH12014502836A1 (en) Medicament form for release of active ingredients
JP2013523758A5 (enExample)
WO2016006975A3 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
EP4234021A3 (en) Pharmaceutical composition comprising an adenosine derivative for use in the prevention or treatment of diabetic nephropathy
WO2019004788A3 (ko) 브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물
JP2018528238A5 (enExample)
JP2016528283A5 (enExample)
HUE071451T2 (hu) Vegyület, gyógyászatilag elfogadható sója vagy optikai izomere, eljárás elõállítására és hatóanyagként azt tartalmazó, vírusos betegség megelõzésére vagy kezelésére szolgáló gyógyászati készítmény
JP2017052778A5 (enExample)
WO2018119108A8 (en) Solid pharmaceutical formulations of asimadoline
JP2018043942A5 (enExample)
JP2018521127A5 (enExample)